Header Logo

Connection

LISA SATTER to Humans

Back to Details
This is a "connection" page, showing publications LISA SATTER has written about Humans.
LISA SATTER
Connection Strength
0.547
Humans
  1. Janus Kinase Inhibitors in Treatment of Primary Immune Regulatory Disorders. J Allergy Clin Immunol Pract. 2026 07; 14(7):1491-1503.
    View in: PubMed
    Score: 0.026
  2. An ELF4 hypomorphic variant results in NK cell deficiency. JCI Insight. 2022 12 08; 7(23).
    View in: PubMed
    Score: 0.021
  3. Monogenic early-onset lymphoproliferation and autoimmunity: Natural history of STAT3 gain-of-function syndrome. J Allergy Clin Immunol. 2023 04; 151(4):1081-1095.
    View in: PubMed
    Score: 0.020
  4. Severe Pediatric COVID-19 Pneumonia Treated With Adjuvant Anakinra. Hosp Pediatr. 2022 05 01; 12(5):e162-e170.
    View in: PubMed
    Score: 0.020
  5. Distract NK cell killing: give them a fatty meal. Blood. 2020 12 24; 136(26):2969-2970.
    View in: PubMed
    Score: 0.018
  6. Case Report: Secondary Hemophagocytic Lymphohistiocytosis With Disseminated Infection in Chronic Granulomatous Disease-A Serious Cause of Mortality. Front Immunol. 2020; 11:581475.
    View in: PubMed
    Score: 0.018
  7. Successful Treatment of Interstitial Lung Disease in STAT3 Gain-of-Function Using JAK Inhibitors. Am J Respir Crit Care Med. 2020 09 15; 202(6):893-897.
    View in: PubMed
    Score: 0.018
  8. Fever and Knee Swelling in a 3-Year-Old Boy. Pediatr Infect Dis J. 2019 09; 38(9):979.
    View in: PubMed
    Score: 0.016
  9. A combined immunodeficiency with severe infections, inflammation, and allergy caused by ARPC1B deficiency. J Allergy Clin Immunol. 2019 06; 143(6):2296-2299.
    View in: PubMed
    Score: 0.016
  10. Genetic and mechanistic diversity in pediatric hemophagocytic lymphohistiocytosis. Blood. 2018 07 05; 132(1):89-100.
    View in: PubMed
    Score: 0.015
  11. Primary immunodeficiency diseases: Genomic approaches delineate heterogeneous Mendelian disorders. J Allergy Clin Immunol. 2017 01; 139(1):232-245.
    View in: PubMed
    Score: 0.013
  12. Rapid molecular diagnostics of severe primary immunodeficiency determined by using targeted next-generation sequencing. J Allergy Clin Immunol. 2016 10; 138(4):1142-1151.e2.
    View in: PubMed
    Score: 0.013
  13. Plasma Metagenomic Sequencing Expedites Diagnosis of Disseminated BCG in an Infant With IKBKB Mutation. Pediatr Infect Dis J. 2022 05 01; 41(5):430-435.
    View in: PubMed
    Score: 0.010
  14. STAT5B restrains human B-cell differentiation to maintain humoral immune homeostasis. J Allergy Clin Immunol. 2022 10; 150(4):931-946.
    View in: PubMed
    Score: 0.010
  15. Diagnostic Modalities in Primary Immunodeficiency. Clin Rev Allergy Immunol. 2022 Aug; 63(1):90-98.
    View in: PubMed
    Score: 0.010
  16. HSCT corrects primary immunodeficiency and immune dysregulation in patients with POMP-related autoinflammatory disease. Blood. 2021 11 11; 138(19):1896-1901.
    View in: PubMed
    Score: 0.010
  17. More on STAT1 Gain of Function, Type 1 Diabetes, and JAK Inhibition. Reply. N Engl J Med. 2021 01 07; 384(1):93-94.
    View in: PubMed
    Score: 0.009
  18. STAT1 Gain of Function, Type 1 Diabetes, and Reversal with JAK Inhibition. N Engl J Med. 2020 10 08; 383(15):1494-1496.
    View in: PubMed
    Score: 0.009
  19. Human diseases caused by impaired signal transducer and activator of transcription and Janus kinase signaling. Curr Opin Pediatr. 2019 12; 31(6):843-850.
    View in: PubMed
    Score: 0.008
  20. Mechanism-Based Precision Therapy for the Treatment of Primary Immunodeficiency and Primary Immunodysregulatory Diseases. J Allergy Clin Immunol Pract. 2019 03; 7(3):761-773.
    View in: PubMed
    Score: 0.008
  21. Clinical Aspects of STAT3 Gain-of-Function Germline Mutations: A Systematic Review. J Allergy Clin Immunol Pract. 2019 Jul - Aug; 7(6):1958-1969.e9.
    View in: PubMed
    Score: 0.008
  22. STAT3 gain of function: a new aetiology of severe rheumatic disease. Rheumatology (Oxford). 2019 02 01; 58(2):365-367.
    View in: PubMed
    Score: 0.008
  23. JAK/STAT proteins and their biological impact on NK cell development and function. Mol Immunol. 2019 11; 115:21-30.
    View in: PubMed
    Score: 0.008
  24. The Impact of Immunodeficiency on NK Cell Maturation and Function. Curr Allergy Asthma Rep. 2019 01 19; 19(1):2.
    View in: PubMed
    Score: 0.008
  25. Novel STAT1 Gain-of-Function Mutation Presenting as Combined Immunodeficiency. J Clin Immunol. 2018 10; 38(7):753-756.
    View in: PubMed
    Score: 0.008
  26. Mutations in PI3K110d cause impaired natural killer cell function partially rescued by rapamycin treatment. J Allergy Clin Immunol. 2018 08; 142(2):605-617.e7.
    View in: PubMed
    Score: 0.007
  27. Ruxolitinib reverses dysregulated T helper cell responses and controls autoimmunity caused by a novel signal transducer and activator of transcription 1 (STAT1) gain-of-function mutation. J Allergy Clin Immunol. 2017 May; 139(5):1629-1640.e2.
    View in: PubMed
    Score: 0.007
  28. IMPACT (Immune Monitoring and Phenotype Assessment of Clinical Trajectory) for Patients With Inborn Errors of Immunity From the Primary Immune Deficiency Treatment Consortium (PIDTC). J Allergy Clin Immunol Pract. 2026 Aug; 14(8):1893-1900.
    View in: PubMed
    Score: 0.007
  29. Copa Syndrome: a Novel Autosomal Dominant Immune Dysregulatory Disease. J Clin Immunol. 2016 05; 36(4):377-387.
    View in: PubMed
    Score: 0.006
  30. Hematopoietic cell transplantation for Wiskott-Aldrich syndrome: a PIDTC report. Blood Adv. 2026 Mar 10; 10(5):1783-1798.
    View in: PubMed
    Score: 0.006
  31. Disease-causing STAT3 variants can be discriminated by a functional flow cytometry test. Pediatr Allergy Immunol. 2026 Feb; 37(2):e70300.
    View in: PubMed
    Score: 0.006
  32. Multidisciplinary approach to treating complex immune dysregulation disorders: an adaptive model for institutional implementation. Front Immunol. 2025; 16:1519955.
    View in: PubMed
    Score: 0.006
  33. Clinical manifestations, disease penetrance, and treatment in individuals with SOCS1 insufficiency: a registry-based and population-based study. Lancet Rheumatol. 2025 Jun; 7(6):e391-e402.
    View in: PubMed
    Score: 0.006
  34. Clinical, immunologic, and genetic characteristics of 148 patients with natural killer cell deficiency. J Allergy Clin Immunol. 2025 May; 155(5):1623-1634.
    View in: PubMed
    Score: 0.006
  35. MYO5B and the Polygenic Landscape of Very Early-Onset Inflammatory Bowel Disease in an Ethnically Diverse Population. Inflamm Bowel Dis. 2025 01 06; 31(1):189-199.
    View in: PubMed
    Score: 0.006
  36. Inborn errors of immunity reveal molecular requirements for generation and maintenance of human CD4+ IL-9-expressing cells. J Allergy Clin Immunol. 2025 Apr; 155(4):1161-1178.
    View in: PubMed
    Score: 0.006
  37. Relevance of lymphocyte proliferation to PHA in severe combined immunodeficiency (SCID) and T cell lymphopenia. Clin Immunol. 2024 04; 261:109942.
    View in: PubMed
    Score: 0.006
  38. JAK/STAT defects and immune dysregulation, and guiding therapeutic choices. Immunol Rev. 2024 03; 322(1):311-328.
    View in: PubMed
    Score: 0.006
  39. Outcomes of hematopoietic stem cell gene therapy for Wiskott-Aldrich syndrome. Blood. 2023 10 12; 142(15):1281-1296.
    View in: PubMed
    Score: 0.005
  40. PLCG2-associated immune dysregulation (PLAID) comprises broad and distinct clinical presentations related to functional classes of genetic variants. J Allergy Clin Immunol. 2024 01; 153(1):230-242.
    View in: PubMed
    Score: 0.005
  41. Activated phosphoinositide 3-kinase d syndrome: Update from the ESID Registry and comparison with other autoimmune-lymphoproliferative inborn errors of immunity. J Allergy Clin Immunol. 2023 10; 152(4):984-996.e10.
    View in: PubMed
    Score: 0.005
  42. Measuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: a 36-year longitudinal study from the Primary Immune Deficiency Treatment Consortium. Lancet. 2023 07 08; 402(10396):129-140.
    View in: PubMed
    Score: 0.005
  43. STAT5b: A master regulator of key biological pathways. Front Immunol. 2022; 13:1025373.
    View in: PubMed
    Score: 0.005
  44. Pediatric autoimmune myelofibrosis: Experience from a large pediatric tertiary care center. Pediatr Blood Cancer. 2023 04; 70(4):e30144.
    View in: PubMed
    Score: 0.005
  45. The diagnosis of severe combined immunodeficiency: Implementation of the PIDTC 2022 Definitions. J Allergy Clin Immunol. 2023 02; 151(2):547-555.e5.
    View in: PubMed
    Score: 0.005
  46. The diagnosis of severe combined immunodeficiency (SCID): The Primary Immune Deficiency Treatment Consortium (PIDTC) 2022 Definitions. J Allergy Clin Immunol. 2023 02; 151(2):539-546.
    View in: PubMed
    Score: 0.005
  47. Outcomes following treatment for ADA-deficient severe combined immunodeficiency: a report from the PIDTC. Blood. 2022 08 18; 140(7):685-705.
    View in: PubMed
    Score: 0.005
  48. IFN-? signature in the plasma proteome distinguishes pediatric hemophagocytic lymphohistiocytosis from sepsis and SIRS. Blood Adv. 2021 09 14; 5(17):3457-3467.
    View in: PubMed
    Score: 0.005
  49. Genetic errors of immunity distinguish pediatric nonmalignant lymphoproliferative disorders. J Allergy Clin Immunol. 2022 02; 149(2):758-766.
    View in: PubMed
    Score: 0.005
  50. Expansion of the clinical phenotype of GALE deficiency. Am J Med Genet A. 2021 10; 185(10):3118-3121.
    View in: PubMed
    Score: 0.005
  51. A Toolkit and Framework for Optimal Laboratory Evaluation of Individuals with Suspected Primary Immunodeficiency. J Allergy Clin Immunol Pract. 2021 09; 9(9):3293-3307.e6.
    View in: PubMed
    Score: 0.005
  52. Infections in Infants with SCID: Isolation, Infection Screening, and Prophylaxis in PIDTC Centers. J Clin Immunol. 2021 01; 41(1):38-50.
    View in: PubMed
    Score: 0.004
  53. Disease-associated CTNNBL1 mutation impairs somatic hypermutation by decreasing nuclear AID. J Clin Invest. 2020 08 03; 130(8):4411-4422.
    View in: PubMed
    Score: 0.004
  54. HEM1 deficiency disrupts mTORC2 and F-actin control in inherited immunodysregulatory disease. Science. 2020 07 10; 369(6500):202-207.
    View in: PubMed
    Score: 0.004
  55. Intralesional Corticosteroids as Adjunctive Therapy for Refractory Cutaneous Lesions in Chronic Granulomatous Disease. J Allergy Clin Immunol Pract. 2020 09; 8(8):2769-2770.
    View in: PubMed
    Score: 0.004
  56. Excellent outcomes following hematopoietic cell transplantation for Wiskott-Aldrich syndrome: a PIDTC report. Blood. 2020 06 04; 135(23):2094-2105.
    View in: PubMed
    Score: 0.004
  57. Hematopoietic Cell Transplantation in Patients With Primary Immune Regulatory Disorders (PIRD): A Primary Immune Deficiency Treatment Consortium (PIDTC) Survey. Front Immunol. 2020; 11:239.
    View in: PubMed
    Score: 0.004
  58. Human signal transducer and activator of transcription 5b (STAT5b) mutation causes dysregulated human natural killer cell maturation and impaired lytic function. J Allergy Clin Immunol. 2020 01; 145(1):345-357.e9.
    View in: PubMed
    Score: 0.004
  59. Chronic Granulomatous Disease-Associated IBD Resolves and Does Not Adversely Impact Survival Following Allogeneic HCT. J Clin Immunol. 2019 10; 39(7):653-667.
    View in: PubMed
    Score: 0.004
  60. Jakinibs for the treatment of immune dysregulation in patients with gain-of-function signal transducer and activator of transcription 1 (STAT1) or STAT3 mutations. J Allergy Clin Immunol. 2018 11; 142(5):1665-1669.
    View in: PubMed
    Score: 0.004
  61. STAT3 Gain of Function: A New Kid on the Block in Interstitial Lung Diseases. Am J Respir Crit Care Med. 2018 06 01; 197(11):e22-e23.
    View in: PubMed
    Score: 0.004
  62. Heterozygous Truncating Variants in POMP Escape Nonsense-Mediated Decay and Cause a Unique Immune Dysregulatory Syndrome. Am J Hum Genet. 2018 06 07; 102(6):1126-1142.
    View in: PubMed
    Score: 0.004
  63. High Incidence of Autoimmune Disease after Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease. Biol Blood Marrow Transplant. 2018 08; 24(8):1643-1650.
    View in: PubMed
    Score: 0.004
  64. Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: An international multicenter retrospective study. J Allergy Clin Immunol. 2018 03; 141(3):1036-1049.e5.
    View in: PubMed
    Score: 0.004
  65. Outcomes after Allogeneic Transplant in Patients with Wiskott-Aldrich Syndrome. Biol Blood Marrow Transplant. 2018 03; 24(3):537-541.
    View in: PubMed
    Score: 0.004
  66. Ruxolitinib partially reverses functional natural killer cell deficiency in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations. J Allergy Clin Immunol. 2018 06; 141(6):2142-2155.e5.
    View in: PubMed
    Score: 0.004
  67. High-resolution phenotyping identifies NK cell subsets that distinguish healthy children from adults. PLoS One. 2017; 12(8):e0181134.
    View in: PubMed
    Score: 0.004
  68. Efficacy, Safety, and Pharmacokinetics of a New 10?% Liquid Intravenous Immunoglobulin Containing High Titer Neutralizing Antibody to RSV and Other Respiratory Viruses in Subjects with Primary Immunodeficiency Disease. J Clin Immunol. 2016 08; 36(6):590-9.
    View in: PubMed
    Score: 0.003
  69. A novel Rab27a mutation binds melanophilin, but not Munc13-4, causing immunodeficiency without albinism. J Allergy Clin Immunol. 2016 08; 138(2):599-601.e3.
    View in: PubMed
    Score: 0.003
  70. Risk Factors and Clinical Significance of Lymphopenia in Survivors of the Fontan Procedure for Single-Ventricle Congenital Cardiac Disease. J Allergy Clin Immunol Pract. 2016 May-Jun; 4(3):491-6.
    View in: PubMed
    Score: 0.003
  71. [Associations of intracranial meningioma and hypophysial adenoma]. Neurologia. 1995 Mar; 10(3):139.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.